Virtual Medicinal Product (VMP) - Pentazocine 60mg/2ml solution for injection ampoules

Name Details

Name Start Date End Date
Name Current Name Pentazocine 60mg/2ml solution for injection ampoules Start Date 09-06-2004 End Date
Previous Name Previous Name Pentazocine 30mg/ml injection 2ml ampoules Start Date 14-03-2003 End Date 08-06-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
2.0
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 3 (CD No Register Exempt Safe Custody)
Route
Intramuscular, Intravenous, Subcutaneous
Form
Solution for injection
Ontology Form/Route
solutioninjection.intramuscular, solutioninjection.intravenous, solutioninjection.subcutaneous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
N02AD01
BNF Start Date End Date
Current BNF 04070200 Start Date 04-04-2022 End Date
Previous BNF 04070200 Start Date 21-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36027711000001105 29-10-2018
322603001 14-03-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Pentazocine lactate Based on Base Substance Pentazocine 30 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 ampoule